The description of increased LCN2 plasma levels during mild-cognitive impairment, and the consequent suggestion that it might be helpful in predicting the progression of this state to Alzheimer’s disease (Choi et al., 2011), should be considered with caution in light of the present results. The gene discussed is LCN2; the disease is early-onset autosomal dominant Alzheimer disease.